[ Price : $8.95]
Rocket Pharmaceuticals says it has reached an agreement with FDA on a pivotal Phase 2 trial of an investigational gene therapy for...[ Price : $8.95]
Eiger Pharmaceuticals says it is shutting down the Phase 3 LIMT-2 trial of peginterferon lambda in patients with chronic hepatitis...[ Price : $8.95]
Two Knobbe Martens attorneys say the Supreme Court could clarify the bounds of federal preemption of state tort claims based on dr...[ Price : $8.95]
The International Society for Pharmaceutical Engineering says FDA should incorporate provisions in an ICH product lifecycle manage...[ Price : $8.95]
FDA clears the Samsung Wellysis units wearable electrocardiography patch, S-Patch Ex.[ Price : $8.95]
The White House credits FDA actions in helping to reduce cancer drug shortages.[ Price : $8.95]
Abbott recalls its Proclaim and Infinity implantable pulse generators due to complaints from patients who are unable to exit MRI m...[ Price : $8.95]
FDA accepts for priority review a Madrigal Pharmaceuticals NDA for resmetirom and its use in treating adult patients with nonalcoh...